ESMC OTC
Escalon Medical Corp.
1W: +5.9%
1M: +2.9%
3M: -5.3%
YTD: +5.9%
1Y: +8.4%
3Y: -28.0%
5Y: -33.3%
$0.18
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$12M
+0.5% ▲
5Y CAGR: +5.1%
Gross Profit
$6M
+7.1% ▲
5Y CAGR: +5.6%
Operating Income
$133K
+227.5% ▲
Net Income
$106K
+184.2% ▲
EPS (Diluted)
$0.00
+108.4% ▲
EBITDA
$166K
+384.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $10M | $11M | $12M | $12M | $12M |
| YoY Growth | +11.4% | +2.2% | +13.8% | -1.6% | +0.5% |
| Cost of Revenue | $6M | $6M | $7M | $7M | $7M |
| Gross Profit | $4M | $5M | $5M | $5M | $6M |
| Gross Margin | 42.3% | 43.0% | 45.0% | 43.0% | 45.7% |
| R&D Expenses | $890K | $991K | $819K | $688K | $753M |
| SG&A Expenses | $4M | $4M | $4M | $5M | $4.6B |
| Operating Expenses | $4M | $5M | $5M | $5M | $5M |
| Operating Income | -$30K | $36K | $479K | -$104K | $133K |
| Operating Margin | -0.3% | 0.3% | 3.9% | -0.9% | 1.1% |
| Interest Expense | $22K | $18K | $22K | $21K | $23M |
| Income Before Tax | -$52K | $18K | $457K | -$125K | $106K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$76K | $18K | $457K | -$125K | $106K |
| Net Margin | -0.7% | 0.2% | 3.8% | -1.0% | 0.9% |
| EPS (Diluted) | $-0.01 | $0.00 | $0.03 | $-0.02 | $0.00 |
| EBITDA | $289K | $365K | $524K | -$58K | $166K |
| Shares Outstanding | 7M | 7M | 14M | 7M | 14M |